CHINA SHINEWAY PHARMACEUTICAL GR revenue breakdown overview

CHINA SHINEWAY PHARMACEUTICAL GR revenue for the last year amounted to 4.02 B HKD, the most of which — 1.37 B HKD — came from its highest performing source at the moment, Injections, the year earlier bringing 1.97 B HKD. The greatest contribution to the revenue figure was made by China including Hong Kong — last year it brought CHINA SHINEWAY PHARMACEUTICAL GR 4.10 B HKD, and the year before that — 4.99 B HKD.